-
SAME GENERATION, DIFFERENT STATE: REGIONAL DISPARITIES IN SICK LEAVE ACROSS BABY BOOMERS, GEN-X, MILLENNIALS, AND GEN-Z IN GERMANY
Aug 11, 2026, 17:16 PM -
CHALLENGE OF ATMP REIMBURSEMENT AND PATIENT ACCESS IN A CHANGING UK LANDSCAPE
Aug 11, 2026, 17:16 PM -
DIVERSITY IN HEALTH TECHNOLOGY ASSESSMENT (HTA) PRACTICES ACROSS LATIN AMERICA: A CROSS-COUNTRY REVIEW OF DECISION FRAMEWORKS, EVIDENCE REQUIREMENTS AND ACCESS LINKAGES
Aug 11, 2026, 17:16 PM -
ECONOMIC IMPACT OF A RAPID APOE4 CARRIER TRIAGE STRATEGY FOR ALZHEIMER'S DISEASE: A COST-MINIMIZATION ANALYSIS ACROSS FOUR COUNTRIES
Aug 11, 2026, 17:16 PM -
FROM PATIENT EXPERIENCE TO HEALTH OUTCOMES: UNDERSTANDING THE PATHWAYS IN CANCER CARE
Aug 11, 2026, 17:16 PM -
MODELING THE IMPACT OF SCALE-UP OF LONG-ACTING INJECTABLE PRE-EXPOSURE PROPHYLAXIS (LAI PREP) FOR HIV PREVENTION INBRAZIL: A HIGH-IMPACT INVESTMENT IN HIV PREVENTION
Aug 11, 2026, 17:16 PM -
PULSE CHECK: COMPARISON OF REPORTED AI-ASSISTED METHODS IN ONCOLOGY AND CARDIOVASCULAR DISEASE PROSPERO-REGISTERED SLR PROTOCOLS
Aug 11, 2026, 17:16 PM -
ECONOMIC AND HUMANISTIC OUTCOMES OF DESIDUSTAT VERSUS ERYTHROPOIETIN IN DIALYSIS-DEPENDENT CKD PATIENTS: EVIDENCE FOR VALUE-BASED KIDNEY CARE
Aug 11, 2026, 17:16 PM -
PATIENT AND CAREGIVER EXPERIENCES OF PANCREATIC CANCER IN SWEDEN: QUALITATIVE INSIGHTS TO INFORM EARLY DETECTION STRATEGIES WITHIN THE SHIELD EU PROJECT
Aug 11, 2026, 17:16 PM -
INFLUENCING FACTORS OF PRICE REDUCTION FOR INNOVATIVE ANTICANCER DRUGS IN CHINA'S NATIONAL REIMBURSEMENT DRUG LIST NEGOTIATIONS FROM 2017 TO 2024
Aug 11, 2026, 17:16 PM -
ARTIFICIAL INTELLIGENCE IN HEALTH SETTINGS: A THEMATIC ANALYSIS OF PATIENT AND PUBLIC PERSPECTIVES ON UTILITY AND CONCERNS
Aug 11, 2026, 17:16 PM -
FACETS: AN UNCERTAINTY-AWARE PATIENT-LEVEL SURVIVAL SIMULATION FRAMEWORK FOR PRECISION HEALTH TECHNOLOGY ASSESSMENT: VALIDATION ACROSS REDUCED AND ENRICHED METABRIC BREAST CANCER COHORTS
Aug 11, 2026, 17:16 PM -
A SUMMARY OF GUIDANCE AND METHODS FOR IDENTIFICATION OF PROGNOSTIC FACTORS IN A SYSTEMATIC REVIEW FOR A JCA DOSSIER EVIDENCE SYNTHESIS WORKFLOW
Aug 11, 2026, 17:16 PM -
GROWTH IN ADVANCED-STAGE CANCER TREATMENT COSTS IN ENGLAND REFLECTING RISING CANCER PRESCRIBING EXPENDITURES
Aug 11, 2026, 17:16 PM -
REAL-WORLD EPIDEMIOLOGY, TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN DUBAI
Aug 11, 2026, 17:16 PM -
BURDEN OF HARD-TO-HEAL WOUNDS IN SPAIN: CLINICAL AND ECONOMIC IMPACT, AND THE POTENTIAL OF HEALTH TECHNOLOGIES
Aug 11, 2026, 17:16 PM -
LIPOSOMAL IRINOTECAN IN COMBINATION WITH OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN (NALIRIFOX) FOR THE FIRST-LINE TREATMENT OF ADULT PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE PANCREAS. A BUDGET IMPACT ANALYSIS IN GREECE
Aug 11, 2026, 17:16 PM -
PREVALENCE OF POTENTIALLY INAPPROPRIATE PRESCRIBING (PIP) IN OLDER ADULTS IN 2025 IN THE UNITED STATES: CAN WE DO BETTER IN THE DIGITAL AGE?
Aug 11, 2026, 17:16 PM -
INCORPORATING RISK PREFERENCES INTO VALUE ASSESSMENT FOR ALZHEIMER'S DISEASE: A DISCRETE CHOICE EXPERIMENT USING THE GRACE FRAMEWORK
Aug 11, 2026, 17:16 PM -
SHIFTING PATTERNS IN HEALTHCARE UTILIZATION IN TURKIYE: AN ANALYSIS OF HOSPITAL ADMISSION TRENDS UTILIZING SOCIAL SECURITY INSTITUTION (SGK) DATA (2022-2025)
Aug 11, 2026, 17:16 PM
